Innovation needs
an environment

The Mii Lab is where we take ideas to proof of concept. Where opportunities become products.

Headquartered in Rehovot, in the heart of Israel’s bio-research Mecca and adjacent to the famous Weizmann Institute, MII labs brings scientists and clinicians, entrepreneurs and big pharma together in a unique excellence center conducive to great breakthroughs in dermatology with a clear path to market.

Mission:

To take‮ ‬dermatology and‮ ‬skin care innovations from inception to clinical proof of concept in the shortest‭, ‬most effective and lean way while positioning it for the next steps of high-quality pharmaceutical development‭.‬

The lab brings invaluable expertise and experience working with a range of active ingredients including poorly soluble compounds, new chemical entities (NCEs), small and large molecules, pro-drugs, and high potency compounds.

From concept to creation

With a focus on topical drug development, we have created a closed garden of innovation with built-in synergies – from concept to clinical proof,
for dermatological and skin-care technologies.

Wii are Mii

Among our team members we have more than 120 patents registered, a large variety of pre-clinical and clinical studies conducted across all phases, dozens of pharmaceutical and cosmetic products brought to market, and companies formed and exited with huge value created.

Inbal Ziv
CEO

Inbal brings over 15 years of practical knowledge of topical development products: Formulation design, CMC,  Scale up and GMP manufacturing. Prior to joining MII Labs Inbal Served as the CTO at Intercosma, one of Israel’s leading cosmetics and health care companies. 

Formerly, Inbal held various development positions at Foamix, which is a company specializing in the development of foams for the treatment of skin disorders. During her work at Foamix, Inbal was responsible for the scale up unit and for the clinical batch production.

Inbal was been involved in the development of very challenging skin delivery systems and developed quit a few pharmaceutical and cosmetic products that are being used worldwide.

During her career, Inbal works in collaboration with big pharma companies such as Galderma, Dr. Reddy’s, Bayer, and more.

Inbal earned a bachelor’s degree in Biotechnology Engineering in Israel and an MBA.

READ MORE

Limor Regev Yuzik
CFO

Limor’s extensive experience in financial and accounting matters gives her a unique perspective on the financial management of corporations and funds.

Formerly, Limor held a position as a controller at Viola Group, a leading technology focused investment group, where she was responsible on the holding companies in all financial aspects including accounting, reporting, taxation, budgeting and cash flow.

Prior to that Limor held the position of the controller of Viola Partners, an exclusive investment fund tailored especially for private investors, family offices and foundations.

In addition, Limor served as a financial audit manager at BDO, in companies that worked both in the United States and in the Israeli accounting standards.

Limor holds a B.A. in Economic and Accounting from the Hebrew University of Jerusalem and is registered as a Certified Public Accountant (CPA) in Israel.

READ MORE

Dr. Oron Yacoby-Zeevi
CTO

Dr. Yacoby Zeevi has more than 20 years of extensive scientific experience with both private and publicly listed companies in the biopharmaceutical industry. She joined Neuroderm (formerly Nasdaq: NDRM), a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system (CNS) disorders in 2008 as the Vice President of R&D. From 2016 until her departure in 2018, she served as Chief Scientific Officer. Neuroderm was sold to Mitsubishi Tanabe Pharma for US $1.1 billion in July 2017.

Dr. Yacoby Zeevi is the inventor of over 65 issued patents and patent applications. Her expertise lies in industry-oriented innovation and scientific research, accelerating and orchestrating the evolution of new ideas through R&D proof of concept, intellectual property development, chemistry and manufacturing controls (CMC), early efficacy and safety trials, regulatory affairs and market landscape mapping in fields of unmet medical needs. She earned her Ph.D. in microbiology and immunology from Ben Gurion University in Be’er ShevaIsrael and holds a degree of Doctor in Veterinary Medicine from the Hebrew University of Jerusalem.

READ MORE

Prof. Yuval Ramot
Chief Medical Officer

Associate Professor of Dermatology and Venereology, Hadassah – Hebrew University
Medical Center, Jerusalem, Israel.
Yuval Ramot holds an MD and an MSc degree in Biochemistry from the Hebrew
University of Jerusalem, Israel. Following his medical training, he has specialized in
hair research in the Department of Dermatology in Lübeck University, Germany.
Later, he joined the Department of Dermatology in Hadassah and the Center for
Genetic Diseases of the Skin and Hair and focused on research of genetic skin and
hair diseases and toxicology of the skin. His main clinical interests are hair disorders
and inflammatory diseases of the skin, and he is the director of the psoriasis and
hidradenitis suppurativa clinics in Hadassah. He is the recipient of the Minerva Post-
doctoral Fellowship and the Young Dermatologist International Achievement Award.
He is a member of the European Hair Research Society board and the Israel Society
of Dermatology and Venereology board. In addition, he is part of the Editorial Board
of Experimental Dermatology. He has co-authored 10 chapters in books and more
than 165 articles in peer-reviewed journals.

READ MORE

Yonit Zarfati
Operations & Preclinical Manager

Yonit has over thirteen years of industry experience, in pre-clinical development and project management.

Prior to working at MII Labs, Yonit was project manager at OWC Pharmaceutical Research a company specialized in developing cannabis-based novel products.

In the past, Yonit served as Director, pre-clinical development and operation at NeuroDerm (acquired by Mitsubishi Tanabe for 1.1$ billion). NeuroDerm is a clinical-stage pharmaceutical company developing treatments for central nervous system (CNS) disorders.

Yonit has M.Sc in Immunology from Tel-Aviv university and B.Sc in general biology from Bar-Ilan university.

READ MORE

Dr. Tal Berman
Senior R&D Advisor

Dr. Berman has over thirteen years of industry experience, in drug development and formulation.

Previously, Tal held positions as project manager and QC lab manager at Foamix pharmaceutical, a company specializing in the development of foams for the treatment of skin disorders. In addition,  Tal was project manager at LipoCure, a company developing liposome-based nano-drugs.

Dr. Berman has filed more than 35 patent applications in the area of foam, semi-solids and liposomal formulations.

Dr. Berman has a PhD in biochemistry from the Hebrew university; MSc from Bar-Ilan university, in martials chemistry and; BSc from Bar-Ilan university in medicinal chemistry.

READ MORE

Dr. Arik Tzour
Clinical Manager

Dr. Arik Tzour (Ph.D.) holds a bachelor’s degree in Chemistry, Physics, Maths and Biology (2007) a Master’s in Neurobiology and Physiology (2010), and a Ph.D. in Neurobiology and Physiology (2015) from the School of Medicine, the Hebrew University of Jerusalem, Israel. 

Arik holds Biostatistics and CRA/GCP certificates. 
Arik has more than 6 years of experience in clinical trials as a consultant, clinical trial manager, and clinical science manager. 
Today Arik serves as a Clinical and Preclinical Manager at MII Labs Company.

 
READ MORE

Miri  Refael
QA Manager

Miri has over 10 years of experience in QA in the Biopharma industry.

Previously, Miri was a QA specialist in Scivac Ltd. (sterile vaccine production) and experienced in various quality topics and quality systems implementation. Prior to Scivac, she supported quality activities of the production plant in Phibro Vaccines (Veterinary company).

Miri has a B.Med.Lab.Sc. from the Ben Gurion University of the Negev, Be’er Sheva, and an M.Sc. in Bio-Medical Sciences from the  Hebrew University, Jerusalem.

READ MORE

Ortal Shalom
Project Manager

Ortal Shalom is a Chemical Engineer who was specialized in formulation development in the Pharmaceutical industry.

Previously, Ortal held a few positions in Sol-gel, a dermatology company specializing in developing products for acne and psoriasis, using microencapsulation technology.

Ortal started as an R&D researcher developing creams and gels formulations, and continued to the engineering department, taking part in pharmaceutical development, scale-up and tech-transfer to various CMO’s.

Later on, Ortal was a laboratory manager and head formulator in the cosmetic industry, her job entailed the developing new formulations, testing them and providing the final product.

Ortal holds a B.Sc. degree in chemical engineering from Shenkar college.

 

READ MORE

Daria Lisovets
Analytical Supervisor

Ms. Lisovets has extensive experience in biotechnology and pharmaceutical companies, mostly in investigational drug development and characterization of bio generics, recombinant human proteins and innovative drugs.

As part of her work, Daria is responsible for ongoing management of the laboratory, development of analytical methods, QC testing, stability monitoring, product release and product development support. Daria served as Analytical researcher at Mapi pharma (2017-2018), Research assistant at InSight Biopharmaceuticals (2011-2017) and QC analyst at Chemagis (now Perrigo) in 2010.

Daria hold BSc. in chemistry from Ben Gurion University.

READ MORE

Nir Rapaport
Formulation Scientist

Mr. Rapaport brings over 16 years of practical knowledge,  he has a wide range of professional experience in the biopharmaceutical industry including formulation development, preclinical and  animal models skills, pharmacological procedures and performance of bioanalytical assays.

Mr. Rapaport had a position of Research Assistant in Marval pharma, Research Assistant in Chiasma Pharma, Research Assistant in Prochon Biotech from and Research Assistant in Keryx Biopharmaceuticals.

Mr. Rapaport earned his B.Sc. in animal studies from the Hebrew University.

READ MORE

Inna Zigboim
Director of Administration

Inna has near 20 years of experience in HR & General Office Management Operations, with a demonstrated history of working in multiple industries: pharma, informational technology and services.

Inna spends the past 5 years leading overall internal business operations and projects at several start-up companies.

READ MORE

Inbal Ziv
CEO

Inbal brings over 15 years of practical knowledge of topical development products: Formulation design, CMC,  Scale up and GMP manufacturing. Prior to joining MII Labs Inbal Served as the CTO at Intercosma, one of Israel’s leading cosmetics and health care companies. 

Formerly, Inbal held various development positions at Foamix, which is a company specializing in the development of foams for the treatment of skin disorders. During her work at Foamix, Inbal was responsible for the scale up unit and for the clinical batch production.

Inbal was been involved in the development of very challenging skin delivery systems and developed quit a few pharmaceutical and cosmetic products that are being used worldwide.

During her career, Inbal works in collaboration with big pharma companies such as Galderma, Dr. Reddy’s, Bayer, and more.

Inbal earned a bachelor’s degree in Biotechnology Engineering in Israel and an MBA.

READ MORE

Limor Regev Kuzik
CFO

Limor’s extensive experience in financial and accounting matters gives her a unique perspective on the financial management of corporations and funds.

Formerly, Limor held a position as a controller at Viola Group, a leading technology focused investment group, where she was responsible on the holding companies in all financial aspects including accounting, reporting, taxation, budgeting and cash flow.

Prior to that Limor held the position of the controller of Viola Partners, an exclusive investment fund tailored especially for private investors, family offices and foundations.

In addition, Limor served as a financial audit manager at BDO, in companies that worked both in the United States and in the Israeli accounting standards.

Limor holds a B.A. in Economic and Accounting from the Hebrew University of Jerusalem and is registered as a Certified Public Accountant (CPA) in Israel.

READ MORE

Dr. Oron Yacoby-Zeevi
CTO

Dr. Yacoby Zeevi has more than 20 years of extensive scientific experience with both private and publicly listed companies in the biopharmaceutical industry. She joined Neuroderm (formerly Nasdaq: NDRM), a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system (CNS) disorders in 2008 as the Vice President of R&D. From 2016 until her departure in 2018, she served as Chief Scientific Officer. Neuroderm was sold to Mitsubishi Tanabe Pharma for US $1.1 billion in July 2017.

Dr. Yacoby Zeevi is the inventor of over 65 issued patents and patent applications. Her expertise lies in industry-oriented innovation and scientific research, accelerating and orchestrating the evolution of new ideas through R&D proof of concept, intellectual property development, chemistry and manufacturing controls (CMC), early efficacy and safety trials, regulatory affairs and market landscape mapping in fields of unmet medical needs. She earned her Ph.D. in microbiology and immunology from Ben Gurion University in Be’er ShevaIsrael and holds a degree of Doctor in Veterinary Medicine from the Hebrew University of Jerusalem.

READ MORE

Prof. Yuval Ramot
Chief Medical Officer

Associate Professor of Dermatology and Venereology, Hadassah – Hebrew University
Medical Center, Jerusalem, Israel.
Yuval Ramot holds an MD and an MSc degree in Biochemistry from the Hebrew
University of Jerusalem, Israel. Following his medical training, he has specialized in
hair research in the Department of Dermatology in Lübeck University, Germany.
Later, he joined the Department of Dermatology in Hadassah and the Center for
Genetic Diseases of the Skin and Hair and focused on research of genetic skin and
hair diseases and toxicology of the skin. His main clinical interests are hair disorders
and inflammatory diseases of the skin, and he is the director of the psoriasis and
hidradenitis suppurativa clinics in Hadassah. He is the recipient of the Minerva Post-
doctoral Fellowship and the Young Dermatologist International Achievement Award.
He is a member of the European Hair Research Society board and the Israel Society
of Dermatology and Venereology board. In addition, he is part of the Editorial Board
of Experimental Dermatology. He has co-authored 10 chapters in books and more
than 165 articles in peer-reviewed journals.

READ MORE

Yonit Zarfati
Operations & Preclinical Manager

Yonit has over thirteen years of industry experience, in pre-clinical development and project management.

Prior to working at MII Labs, Yonit was project manager at OWC Pharmaceutical Research a company specialized in developing cannabis-based novel products.

In the past, Yonit served as Director, pre-clinical development and operation at NeuroDerm (acquired by Mitsubishi Tanabe for 1.1$ billion). NeuroDerm is a clinical-stage pharmaceutical company developing treatments for central nervous system (CNS) disorders.

Yonit has M.Sc in Immunology from Tel-Aviv university and B.Sc in general biology from Bar-Ilan university.

READ MORE

Dr. Tal Berman
Senior R&D
Advisor

Dr. Berman has over thirteen years of industry experience, in drug development and formulation.

Previously, Tal held positions as project manager and QC lab manager at Foamix pharmaceutical, a company specializing in the development of foams for the treatment of skin disorders. In addition,  Tal was project manager at LipoCure, a company developing liposome-based nano-drugs.

Dr. Berman has filed more than 35 patent applications in the area of foam, semi-solids and liposomal formulations.

Dr. Berman has a PhD in biochemistry from the Hebrew university; MSc from Bar-Ilan university, in martials chemistry and; BSc from Bar-Ilan university in medicinal chemistry.

READ MORE

Dr. Arik Tzour
Clinical Manager

Dr. Arik Tzour (Ph.D.) holds a bachelor’s degree in Chemistry, Physics, Maths and Biology (2007) a Master’s in Neurobiology and Physiology (2010), and a Ph.D. in Neurobiology and Physiology (2015) from the School of Medicine, the Hebrew University of Jerusalem, Israel. 

Arik holds Biostatistics and CRA/GCP certificates. 
Arik has more than 6 years of experience in clinical trials as a consultant, clinical trial manager, and clinical science manager. 
Today Arik serves as a Clinical and Preclinical Manager at MII Labs Company.

 
READ MORE

Miri  Refael
QA Manager

Miri has over 10 years of experience in QA in the Biopharma industry.

Previously, Miri was a QA specialist in Scivac Ltd. (sterile vaccine production) and experienced in various quality topics and quality systems implementation. Prior to Scivac, she supported quality activities of the production plant in Phibro Vaccines (Veterinary company).

Miri has a B.Med.Lab.Sc. from the Ben Gurion University of the Negev, Be’er Sheva, and an M.Sc. in Bio-Medical Sciences from the  Hebrew University, Jerusalem.

READ MORE

Ortal Shalom
Project Manager

Ortal Shalom is a Chemical Engineer who was specialized in formulation development in the Pharmaceutical industry.

Previously, Ortal held a few positions in Sol-gel, a dermatology company specializing in developing products for acne and psoriasis, using microencapsulation technology.

Ortal started as an R&D researcher developing creams and gels formulations, and continued to the engineering department, taking part in pharmaceutical development, scale-up and tech-transfer to various CMO’s.

Later on, Ortal was a laboratory manager and head formulator in the cosmetic industry, her job entailed the developing new formulations, testing them and providing the final product.

Ortal holds a B.Sc. degree in chemical engineering from Shenkar college.

 

READ MORE

Daria Lisovets
Analytical Supervisor

Ms. Lisovets has extensive experience in biotechnology and pharmaceutical companies, mostly in investigational drug development and characterization of bio generics, recombinant human proteins and innovative drugs.

As part of her work, Daria is responsible for ongoing management of the laboratory, development of analytical methods, QC testing, stability monitoring, product release and product development support. Daria served as Analytical researcher at Mapi pharma (2017-2018), Research assistant at InSight Biopharmaceuticals (2011-2017) and QC analyst at Chemagis (now Perrigo) in 2010.

Daria hold BSc. in chemistry from Ben Gurion University.

READ MORE

Nir Rapaport
Formulation Scientist

Mr. Rapaport brings over 16 years of practical knowledge,  he has a wide range of professional experience in the biopharmaceutical industry including formulation development, preclinical and  animal models skills, pharmacological procedures and performance of bioanalytical assays.

Mr. Rapaport had a position of Research Assistant in Marval pharma, Research Assistant in Chiasma Pharma, Research Assistant in Prochon Biotech from and Research Assistant in Keryx Biopharmaceuticals.

Mr. Rapaport earned his B.Sc. in animal studies from the Hebrew University.

READ MORE

Inna Zigboim
Director of Administration

Inna has near 20 years of experience in HR & General Office Management Operations, with a demonstrated history of working in multiple industries: pharma, informational technology and services.

Inna spends the past 5 years leading overall internal business operations and projects at several start-up companies.

READ MORE